Double-blind comparison between inverse sequence induction with atracurium and rapid sequence induction with...

Area of Science:

• Anesthesiology
• Critical Care Medicine
• Pharmacology

Background:

• Rapid sequence induction (RSI) is a critical procedure for airway management.
• Succinylcholine is a common agent for RSI but has contraindications.
• Alternative techniques are needed for patients where succinylcholine cannot be used.

Purpose of the Study:

• To compare the safety and efficacy of the inverse sequence induction technique (ISI) against standard RSI using succinylcholine (SUX).
• To evaluate intubation conditions, patient vitals, and potential adverse effects of ISI.

Main Methods:

• A double-blind randomized study involving 60 patients.
• Comparison of ISI (atracurium followed by thiopental) with standard RSI (atracurium, thiopental, and succinylcholine).
• Assessment of intubation scores, times, hemodynamic parameters, and SpO2/EtCO2.

Main Results:

• No significant differences in intubation scores or times between ISI and SUX groups.
• Hemodynamic parameters (mean arterial pressure, heart rate) and respiratory measures (SpO2, EtCO2) were similar.
• Three patients in the ISI group experienced transient handgrip weakness; all patients could cough.

Conclusions:

• Inverse sequence induction technique (ISI) is a reliable and safe alternative to succinylcholine for rapid sequence induction.
• ISI demonstrates comparable intubation success and patient safety profiles to standard RSI.
• Patient acceptance of ISI may be limited by the potential for awake partial curarization.